Cargando…
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
Background: Sagopilone (ZK 219477), a lipophylic and synthetic analog of epothilone B, that crosses the blood–brain barrier has demonstrated preclinical activity in glioma models. Patients and methods: Patients with first recurrence/progression of glioblastoma were eligible for this early phase II a...
Autores principales: | Stupp, R., Tosoni, A., Bromberg, J. E. C., Hau, P., Campone, M., Gijtenbeek, J., Frenay, M., Breimer, L., Wiesinger, H., Allgeier, A., van den Bent, M. J., Bogdahn, U., van der Graaf, W., Yun, H. J., Gorlia, T., Lacombe, D., Brandes, A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164435/ https://www.ncbi.nlm.nih.gov/pubmed/21321091 http://dx.doi.org/10.1093/annonc/mdq729 |
Ejemplares similares
-
Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial
por: Arnold, D, et al.
Publicado: (2009) -
Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer
por: McMeekin, S, et al.
Publicado: (2012) -
Molecular Mode of Action and Role of TP53 in the Sensitivity to the
Novel Epothilone Sagopilone (ZK-EPO) in A549 Non-Small Cell Lung Cancer
Cells
por: Winsel, Sebastian, et al.
Publicado: (2011) -
Enabling Blockchain Services for IoE with Zk-Rollups
por: Lavaur, Thomas, et al.
Publicado: (2022) -
Potential inhibitory effects of compounds ZK-PI-5 and ZK-PI-9 on trehalose and chitin metabolism in Spodoptera frugiperda (J. E. Smith)
por: Zhong, Fan, et al.
Publicado: (2023)